(Q41628950)

5 October 2017

1 reference

title

Adenoviral vectors for gene transfer (English)

1 reference

5 October 2017

1 reference

1

1 reference

5 October 2017

Brough DE

2

1 reference

5 October 2017

Bruder JT

series ordinal

3

1 reference

5 October 2017

Wickham TJ

series ordinal

4

1 reference

5 October 2017

publication date

1 October 1997

1 reference

Current Opinion in Biotechnology

5 October 2017

published in

1 reference

5 October 2017

volume

8

1 reference

5 October 2017

issue

5

1 reference

5 October 2017

page(s)

583-589

1 reference

Transfer of genes to humans: early lessons and obstacles to success

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Replicating vectors for gene therapy of cancer: risks, limitations and prospects.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Studies on the use of viruses in the treatment of carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

293 cell lines that inducibly express high levels of adenovirus type 5 precursor terminal protein

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Characterization of a replication-incompetent adenovirus type 5 mutant deleted for the preterminal protein gene

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Isolation and analysis of adenovirus type 5 mutants containing deletions in the gene encoding the DNA-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Effect of the E4 region on the persistence of transgene expression from adenovirus vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Persistence in muscle of an adenoviral vector that lacks all viral genes

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Role of early region 3 (E3) in pathogenesis of adenovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Role of early genes in pathogenesis of adenovirus pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Pulmonary inflammation induced by incomplete or inactivated adenoviral particles

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Role of adenovirus antigens in the induction of virus neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

"Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Nondepleting anti-CD4 antibody treatment prolongs lung-directed E1-deleted adenovirus-mediated gene expression in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Use of transient CD4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Comparative analysis of adenovirus fiber-cell interaction: adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Targeted gene delivery by tropism-modified adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2897%2980033-X

7 January 2021

10.1016/S0958-1669(97)80033-X

Identifiers

DOI

1 reference

5 October 2017

1 reference